Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy
- 27 July 2021
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Cardiovascular Journal
- Vol. 55 (5) , 300-307
Abstract
The incidence of sudden cardiac death (SCD) following heart transplantation (HTx) accounts for approximately 10% of post-HTx deaths. Ischemia, brady- and tachy-arrhythmias caused by rejection and cardiac allograft vasculopathy (CAV) seem related to SCD. Hence, we aimed to investigate the relation between CAV, arrhythmias and silent ischemia in long-term HTx patients. Methods. 49 HTx patients were included. Patients were CAV classified in accordance with guidelines from the International Society of Heart and Lung Transplantation. Patients were divided into predefined CAV groups (CAV 0, CAV 1, CAV 2 + 3). Incidences of arrhythmia and silent ischemia were detected by 48-h electrocardiogram monitoring and analyzed blinded to CAV-status. Results. Median time since transplantation was 9 years [IQR 4–14]. We observed a higher incidence of non-sustained ventricular tachycardia (NSVT) in CAV 2 + 3 patients than CAV 0 and 1 patients (p = .01). Likewise, isolated premature ventricular complexes (PVC) (p = .01) and PQ-interval prolongation (p = .01) were more frequent in CAV 2 + 3 patients than CAV 0 and 1 patients. Silent ischemia was only observed among CAV 3 patients (p = .04). We saw no significant difference in the incidence of supraventricular tachycardia among CAV groups (p = .21). Likewise, no difference in the right bundle branch block was observed (p = .68). Conclusion. NSVT was associated with CAV status in long-term HTx patients. Patients with moderate to severe CAV showed higher incidences of PVCs and PQ-interval prolongation than patients with mild or no CAV. Silent ischemia was only seen in patients with severe CAV.Keywords
Funding Information
- Aarhus University Research
- Fund
This publication has 26 references indexed in Scilit:
- The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipientsThe Journal of Heart and Lung Transplantation, 2010
- International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010The Journal of Heart and Lung Transplantation, 2010
- Sudden Cardiac Death of Two Heart Transplant Patients With Correctly Functioning Implantable Cardioverter DefibrillatorsThe Journal of Heart and Lung Transplantation, 2009
- Incidence of Atrial Fibrillation in Heart Transplant Patients: Long‐Term Follow‐UpJournal of Cardiovascular Electrophysiology, 2006
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005
- Arrhythmias After Orthotopic Heart TransplantationJournal of Cardiac Failure, 2005
- ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias∗∗This document does not cover atrial fibrillation; atrial fibrillation is covered in the ACC/AHA/ESC guidelines on the management of patients with atrial fibrillation found on the ACC, AHA, and ESC Web sites.—executive summaryJACC, 2003
- ST Segment Analysis by Holter Monitoring:Annals of Noninvasive Electrocardiology, 2003
- Atrial arrhythmias and pacing after orthotopic heart transplantation: bicaval versus standard atrial anastomosis.Heart, 1995
- The effects of sympathetic denervation on spontaneous ventricular defibrillation in the ratCanadian Journal of Physiology and Pharmacology, 1992